Related Experiment Video
Updated: Aug 5, 2026

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
Obesity, macrophage migration inhibitory factor, and weight loss
T S Church1, M S Willis, E L Priest
1The Cooper Institute, 12330 Preston Road, Dallas, TX 75230, USA. tschurch@cooperinst.org
Objective:
Elevated macrophage migration inhibitory factor (MIF) has been implicated as a causal mechanism in a number of disease conditions including cardiovascular disease (CVD), diabetes, and cancer. Excess body fat is associated with an increased risk of numerous health conditions including CVD, diabetes, and cancer. To our knowledge, the association between MIF and obesity status and the effect of weight loss on serum MIF concentrations have not been reported. In this study, we examined the effects of participation in a behavior-based weight loss program on MIF concentrations in obese individuals.
Subjects:
Study participants were 71 men and women enrolled in The Cooper Institute Weight Management Program. Participants were predominantly female (68%, n=48), middle-aged (46.5+/-9.8 y), and severely obese (BMI=43.0+/-8.6).
Method:
Plasma MIF concentrations and other standard risk factors were measured before and after participation in a diet and physical activity based weight management program.
Results:
The mean follow-up was 8.5+/-3.0 months with an average weight loss of 14.4 kg (P<0.001). The majority of clinical risk factors significantly improved at follow-up. Median levels of plasma MIF concentration were significantly lower at follow-up (median [IQR]; 5.1[3.6-10.3]) compared to baseline (8.4 [4.3-48.8]; P=0.0005). The percentage of participants with plasma MIF concentration > or =19.5 mg/nl (highest tertile at baseline) decreased from 33.8 to 5.6% (P<0.001). Further, elevated baseline plasma MIF concentration was associated with markers of beta-cell dysfunction and reductions in MIF were associated with improvements in beta-cell function.
Conclusions:
Circulating MIF concentrations are elevated in obese but otherwise healthy individuals; however, this elevation in MIF is not uniform across individuals. In obese individuals with elevated circulating MIF concentrations, participation in physical activity and a dietary-focused weight management program resulted in substantial reduction in MIF.
Insights
Weight loss programs significantly reduce elevated macrophage migration inhibitory factor (MIF) levels in obese individuals. This reduction in MIF is linked to improved health markers, including better beta-cell function.
Area of Science:
- Biochemistry
- Immunology
- Metabolic Health
Background:
- Elevated macrophage migration inhibitory factor (MIF) is linked to cardiovascular disease (CVD), diabetes, and cancer.
- Obesity is a risk factor for numerous health conditions, including CVD, diabetes, and cancer.
- The relationship between MIF and obesity, and the impact of weight loss on MIF levels, remain understudied.
Purpose of the Study:
- To investigate the association between obesity and serum MIF concentrations.
- To examine the effect of a behavior-based weight loss program on MIF levels in obese individuals.
Main Methods:
- Seventy-one severely obese participants (BMI=43.0+/-8.6) in a weight management program were studied.
- Plasma MIF concentrations and clinical risk factors were measured before and after an 8.5-month diet and physical activity intervention.
- Average weight loss was 14.4 kg.
Main Results:
- Significant improvements were observed in most clinical risk factors post-intervention.
- Median plasma MIF concentrations decreased significantly from 8.4 [4.3-48.8] at baseline to 5.1 [3.6-10.3] at follow-up (P=0.0005).
- The proportion of participants with high MIF levels (> or =19.5 mg/nl) dropped from 33.8% to 5.6% (P<0.001).
- Elevated baseline MIF correlated with beta-cell dysfunction; MIF reduction correlated with improved beta-cell function.
Conclusions:
- Obese individuals often exhibit elevated circulating MIF, though not uniformly.
- Dietary and physical activity-focused weight management programs can substantially reduce MIF levels in obese individuals with elevated concentrations.
- Weight loss interventions show promise for mitigating risks associated with obesity and elevated MIF.
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Obesity

